Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Pelvic Denervation Pilot Trial
NCT07005050Recruiting
- Sponsor
- Verve Medical
- Start
- Jan 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial in hypertension (HTN) (2 arms), sponsored by Verve Medical. Primary endpoint: Primary effectiveness at 2 months. Started Jan 2026; status: recruiting.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07005050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07005050.